Connect with us

Featured

Food Delivery Exploded Into A Multi-billion Dollar Industry

Joe Samuel

Published

on

DELIVERY STOCKS TO BUY

Over the past few years, food delivery stocks have gotten more attention due to technology innovation. A few dominant companies have emerged within a short span of time. The companies are richly valued and the idea of getting food delivered to your doorstep with a few taps on the phone is definitely an idea that appeals to venture capitalists and investors. In 2019 alone, total sales from restaurants generated through food delivery apps are pegged to hit $863 billion and that is, without a doubt a staggering number.

However, when it comes to actually invest in the delivery industry, there is a range of factors that need to be taken into consideration. It may be growing at a fast clip but there are several risks that need to be considered and in addition to that, no single company has yet emerged as a confirmed winner.

Publicly Traded Food Delivery Companies

Some of the bigger publicly traded food delivery companies are GrubHub (GRUB) and UberEats. On the other hand, PostMates has filed its initial public offering already and should start trading at some point this year. GrubHub had its IPO back in 2014 when it was listed at $26 a share and now the shares are priced at $63 each.

However, it has been a tough ride for the company over the past months, as more competition and rising costs had its effect on the financials. In its last reported quarter, sales rose by 39% year on year to hit $324 million, but at the same time, its margins shrunk further to only 2.7%.

On the other hand, UberEats is not separately listed. If an investor wants to buy into the business, then they would need to buy UBER stock at its current stock price. Although UberEats has managed to become the biggest revenue generator for the company, the company’s core business remains ride sharing and hence for an investor, it is a tough decision to invest in Uber. The losses from the ride-hailing business can completely wipe out the positives from the food delivery business and hence it is a risky decision.

Emerging But Competitive Market

ParcelPal (PTNYF) (PKG) is anothing company breaking into the global, on-demand industry and at a rapid pace. The opportunity that ParcelPal (PTNYF) (PKG) may be presenting now draws comparisons to the way early investors had an opportunity with companies like Uber and GrubHub (GRUB) before they went mainstream in the US.

The difference withParcelPal (PTNYF) (PKG) is that it is going directly after the international markets that have very limited access to technology like this right now. In fact, the major players in the industry are just beginning to get their feet wet with beta testing; they aren’t even full speed yet.

Something that is beginning to set ParcelPal (PTNYF) (PKG) apart from its immediate competition is its diversification strategy. Not only is the company working with the likes of Amazon, but it is also entering into key verticals that are seeing an increase in rapid demand. Right now, ParcelPal has built relationships with businesses in both alcohol and cannabis

|REPORT | Special Delivery! On-Demand Tech Companies Hit Billion-Dollar Valuations; Here’s How Investors Can Capitalize In The Market

According to the data collected by the National Technology Readiness Survey in the U.S., it was estimated that total spending on the on-demand mobile app services would increase from $48 billion n 2016 to $75.7 billion in 2017—an increase amounting to 58%.

The segments of the on-demand startup market that have witnessed maximum growth, consist of housing items from $5 billion in ‘16 to $10.6 billion in ‘17; transportation, which moved from $6.8 billion in ‘16 to $14.2 billion in ‘17; and, lastly, the food delivery category, which shifted to $8.2 billion in 2017 from $3.9 billion in 2016.

With the feverish pitch that the global on-demand industry is set to see, can you afford to miss out on something for which early adopters are already earmarking billions of dollars for massive future growth?


DELIVERY STOCKS TO BUY
Disclaimer: MIDAM VENTURES LLC has been compensated $75,000 per month by a ParcelPal Technology, Inc. for a period beginning September 1, 2018 and ending February 1, 2019 to publicly disseminate information about (PTNYF/PKG) to publicly disseminate information about (PTNYF/PKG). Midam Ventures has been compensated $100,000 by Parcel Pal and has extended coverage to April 1, 2019. Midam Ventures has been compensated $100,000 by Parcel Pal and has extended coverage to May 1, 2019. Midam Ventures has been compensated $200,000 by Parcel Pal and has extended coverage to June 1, 2019. Midam Ventures has been compensated $200,000 by Parcel Pal and has extended coverage to July 1, 2019. We may buy or sell additional shares of (PTNYF/PKG) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. We own zero shares. Click Here For Full Disclaimer

Continue Reading
Click to comment

Biotechnology

3 Small-Cap Biotech Stocks To Watch In Coming Weeks

Joe Samuel

Published

on

stock market today

Biotech has been one of the hottest sectors for investors for as long as it has existed and the reasons are self-evident. It is a sector that uses cutting edge technology and comes up with treatments for a wide range of diseases.

Moreover, the fact that biotech companies often improve on existing treatments, makes them a far more attractive target for a range of investors. Here is a look at three biotech stocks to watch during the last few weeks of the quarter.

PharmaCyte Biotech (PMCB)

There has been no lack of attention on biotech penny stocks this year.  At the beginning of August, one small biotech stock broke to highs of over $10 from a starting price below $2 a share after releasing news. PharmaCyte Biotech (PMCB) focuses on ways to effectively deliver treatments to patients with diseases ranging from cancer to diabetes. 

The company’s proprietary cellulose-based live-cell encapsulation technology known as “Cell-in-a-Box®is the platform that the company uses to develop its therapy delivery methods.  For most of the quarter, shares of PMCB stock have traded between $0.033 and $0.04 with volume recently surging.

On September 19, PharmaCyte saw more than 6 million shares trade; well above its daily average. Most of the attention surrounding the company has been on two things. First, its progress with Cell-In-A-Box and the application for Pancreatic cancer has continued to progress. The company brought on Dr. Manuel Hidalgo, has confirmed that he will be Principal Investigator (PI) for PharmaCyte’s planned clinical trial in locally advanced, inoperable pancreatic cancer (LAPC) now that he is at Weill Cornell Medical Center.

What To Watch For

This week PharmaCyte (PMCB) will host a call designed to update all shareholders and the investment community simultaneously of material developments. The call will cover PharmaCyte’s preparations for submission of its Investigational New Drug application (IND) to the U.S. FDA to treat locally advanced, inoperable pancreatic cancer. It will also cover developments related to PharmaCyte’s product pipeline. PharmaCyte has been working on these and will discuss things not yet reported in a press release.

Catalyst Pharmaceuticals (CPRX)

The first one to watch is Catalyst Pharmaceuticals Inc (NASDAQ:CPRX). It is a small-cap stock engaged in developing medicines for rare diseases. Catalyst managed to get an approval for one of its products from the FDA earlier this year.

Since the approval of the Lambert-Eaton myasthenic syndrome (LEMS treating medicine Firdapse, Catalyst stock went on a massive rally from January to April. The approval of a rival drug halted the rally. Only after a civil suit from Catalyst did the stock stabilize somewhat.

Last week, Catalyst stock received a fresh boost after the company announced that it was going to make a secondary offering. However, the company decided to pull the offering the very next day and that affected the stock price once again.

What To Watch For

Analysts believe that pulling the secondary offering was the right long term decisions and this stock could be heading for another rally soon.

Eyepoint Pharmaceuticals (EYPT)

The biotech stock that could prove to be a major winner in the biotech sector this month is that of Eyepoint Pharmaceuticals Inc (NASDAQ:EYPT). There are two factors at play. The company revenues are going to rise significantly in the coming years due to the commercial launch of two medicines.

The first one is Yutiq, which is meant for the treatment of chronic non-infectious uveitis and the other one is Dexycu, which is meant for postoperative ocular inflammation.

What To Watch For

The company is currently trading at only double that of its future revenue and that is a very attractive multiple. EYPT stock has caught the attention of analysts on Wall Street. Guggenheim has set a 12-month target price of $4, which reflects 116% gains during the period.

stock market news today
Disclaimer: Pursuant to an agreement between MIDAM VENTURES, LLC and Complete Investment And Management LLC, a Non-affiliate Third Party, Midam was hired for a period from 07/09/2019 – 8/09/2019 to publicly disseminate information about PharmaCyte Biotech including on the Website and other media including Facebook and Twitter. We were paid $150,000 (CASH) for & were paid “0” shares of restricted common shares. We were paid an additional $150,000 (CASH) BY Complete Investment And Management LLC, a Non-affiliate Third Party, AND HAVE EXTENDED coverage for a period from 8/12/2019 – 9/12/2019. We may buy or sell additional shares of PharmaCyte Biotech in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Click Here For Full Disclaimer

Continue Reading

Featured

Stock Price Newsletter – September 20, 2019

Joe Samuel

Published

on

defense stocks to watch

Microsoft (MSFT) Stock Price Jumps On Increased Dividend and Buyback Announcement

On Wednesday Microsoft Corporation (NASDAQ: MSFT) shares gained 1% in extended trading after the company announced that it was raising its quarterly dividend by $0.05. But there’s more to this story than meets the eye.

Click To Read More


Multi-Billion Dollar Markets Are Ready For A Shake-Up; 1 Biotech Stock Could Hold The Key

There’s no denying that biotechnology is one of the hottest markets in the world. Right now a multi-billion-dollar segment is ready for a shakeup and one biotech stock could hold the secret to doing just that!

Read More


Top 4 Penny Stocks To Watch Right Now

Penny stocks are some of the most active and volatile types of stocks in the stock market today. But what everyone knows about these is that they can break out in a big way. That’s why so many continue to look for the best penny stocks to buy.

See For Yourself

Continue Reading

Featured

Microsoft (MSFT) Stock Price Jumps On Increased Dividend and Buyback Announcement

Joe Samuel

Published

on

On Wednesday Microsoft Corporation (NASDAQ: MSFT) shares gained 1% in extended trading after the company announced that it was raising its quarterly dividend by $0.05.

Share Repurchase Program

The company has also authorized a $40 billion stock buyback. Under the leadership of CEO Satya Nadella, the company has been buying back its shares. In the fiscal year ended June 30, Microsoft bought back it’s a stock worth around $19.54 billion. The year before stock buybacks were around $10.72 billion. In the last five years under the tenure of Nadella, the company has seen it’s stock almost quadruple and exceed a trillion-dollar market cap.

The company has aggressively been repurchasing its stock and at the current rate, they are likely to use all the $40 billion in the latest repurchase program within two years. The new share repurchase program does not have an expiration period but the company could choose to terminate it any time.

Growing Dividends

The company is increasing its dividends by 5 cents barely a year after increased them. The board of directors approved a $0.51 quarterly dividend which reflects an 11% increase over the quarter before. This translates to $2.04 annually. Microsoft has been paying dividends to stockholders since 2003 and it has been pumping up its quarterly dividend each year.

Microsoft has indicated that it will pay shareholders of record on November 21 a dividend of $0.51 on December 12. The 11% increase is an improvement from last year’s dividend increase of 9.5%. The increase is slightly more than the company’s average dividend growth percentage of around 10.4%.

The share repurchase program and dividend increase are a no brainer for Microsoft. In 2019 the company brought around $38.3 billion in free cash flow of which $13.8 billion was given to shareholders in the form of dividends. The company returned around $33 billion to shareholders this is inclusive of the cash spent on stock repurchases.

Considering how trivial the company’s dividends are relative to its free cash flow, it appears like Microsoft will keep increasing its dividends each year.

A Clear Focus On Groundbreaking Technology

Global spending on security solutions is projected to reach $7.4 billion in 2019 and increase to over $11.3 billion by 2025 with a CAGR of 8.2%.  The urban Security explosives and Weapons Detection market is slated to grow to nearly $7.5 billion by 2025 and is forecast to see consistent growth for the next several years [2].

What does this mean? Well, for investors it could signal big opportunities but with so many large companies targeting surveillance systems and weapon detection devices as a “go-to,” is there anything that could truly disrupt this market?

In short, yes

Liberty Defense (SCAN.V) (LDDFF) Is Positioning To Change The Face Of Threat Detection For Good

The truth of the matter is that mass shootings now happen more than once a day in the US and as we’ve come to find, there’s no real way to stop these attacks after an attacker enters a space. This is where the real opportunity is: stopping an attack before someone even enters a vulnerable space.

Liberty Defense (TSX: SCAN.V) (OTC: LDDFF) plans to do that using HEXWAVE, a next-generation high-tech security scanning system that will use advanced, low-power radar, 3D-imaging, and Artificial Intelligence (AI) to screen people at public gatherings such as sports games, unobtrusively.

Liberty Defense (SCAN.V) (LDDFF) Is Positioning To Change The Face Of Threat Detection For Good

The truth of the matter is that mass shootings now happen more than once a day in the US and as we’ve come to find, there’s no real way to stop these attacks after an attacker enters a space. This is where the real opportunity is: stopping an attack before someone even enters a vulnerable space.

Liberty Defense (TSX: SCAN.V) (OTC: LDDFF) plans to do that using HEXWAVE, a next-generation high-tech security scanning system that will use advanced, low-power radar, 3D-imaging, and Artificial Intelligence (AI) to screen people at public gatherings such as sports games, unobtrusively.

Liberty Defense WSJ

The advanced attack prevention system can detect if someone is armed before they enter a building using radar energy and Artificial Intelligence (AI) to detect weapons and explosives in real-time. You may be thinking that the processes and screening technology that you see in airports can achieve the same thing in our communities.  

Urban Threat Detection

But we’re talking about urban detection; where high people traffic flow and attempts to provide airport-like screening processes can be extremely disruptive to business activity because of security entry delays. 

As important to providing a higher rate of threat screening is that there also needs to be a way to detect other potential mass attack weapons including explosives, pyrotechnics and other non-metallic threats.

Utilizing a new disruptive technology under an exclusive global license from MIT (Massachusetts Institute of Technology), Liberty Defense (TSX: SCAN.V) (OTC: LDDFF) is developing HEXWAVE.

Liberty Defense WSJ

The advanced attack prevention system can detect if someone is armed before they enter a building using radar energy and Artificial Intelligence (AI) to detect weapons and explosives in real-time. You may be thinking that the processes and screening technology that you see in airports can achieve the same thing in our communities.  But we’re talking about urban detection; where high people traffic flow and attempts to provide airport-like screening processes can be extremely disruptive to business activity because of security entry delays. 

As important to providing a higher rate of threat screening is that there also needs to be a way to detect other potential mass attack weapons including explosives, pyrotechnics and other non-metallic threats.

Utilizing a new disruptive technology under an exclusive global license from MIT (Massachusetts Institute of Technology), Liberty Defense (TSX: SCAN.V) (OTC: LDDFF) is developing HEXWAVE.

Click Here To Learn More About Liberty Defense and its HEXWAVE

defense stocks weapons detection
Disclaimer: Pursuant to an agreement between MIDAM VENTURES, LLC and Liberty Defense Holdings Inc. Midam was hired for a period from 06/1/2019 – 9/30/2019 to publicly disseminate information about Liberty Defense Holdings Inc. including on the Website and other media including Facebook and Twitter. We were paid $250,000 (CASH) for & were paid “0” shares of restricted common shares. We may buy or sell additional shares of Liberty Defense Holdings Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. For previous compensation see our FULL DISCLAIMER HERE

Continue Reading

Join Our Newsletter

Get stock alerts, news & trending stock alerts straight to your inbox!


Privacy Policy

We keep all user information pricate & promise to never spam.*

Stock Price Free Text List

Search Stock Price (StockPrice.com)




Trending

Subscribe Now & Begin Receiving Free Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Stock Market & Finance, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on stock market & finance related, articles, news and trade alerts. Further questions please contact privacy@stockprice.com